Prognostic Impacts of β-Blockers in Acute Coronary Syndrome Patients without Heart Failure Treated by Percutaneous Coronary Intervention.
Sign Up to like & getrecommendations! Published in 2021 at "Pharmacological research"
DOI: 10.1016/j.phrs.2021.105614
Abstract: BACKGROUND The use of β-blockers for acute coronary syndrome (ACS) patients without heart failure (HF) is controversial, and lacks of evidence in the era of reperfusion and intensive secondary preventions. This study aimed to investigate… read more here.
Keywords: analysis; impacts blockers; acute coronary; prognostic impacts ... See more keywords
Prognostic impacts of soluble immune checkpoint regulators and cytokines in patients with SARS-CoV-2 infection
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Immunology"
DOI: 10.3389/fimmu.2022.903419
Abstract: Coronavirus disease 2019 (COVID-19) has been a pandemic for the past two years. Predicting patient prognosis is critical. Although immune checkpoints (ICs) were shown to be involved in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)… read more here.
Keywords: second week; prognostic impacts; patients sars; cov infection ... See more keywords
Prognostic Impacts of LL-37 in Relation to Lipid Profiles of Patients with Myocardial Infarction: A Prospective Cohort Study
Sign Up to like & getrecommendations! Published in 2022 at "Biomolecules"
DOI: 10.3390/biom12101482
Abstract: Background. In vivo studies show that LL-37 inhibits the progression of atherosclerosis and predicts a lower risk of recurrent ischemia in patients with acute myocardial infarction (AMI), which could be mediated by the modulation of… read more here.
Keywords: myocardial infarction; impacts relation; prognostic impacts; lipid profiles ... See more keywords